KFRC Stock Cash Flow Statements

Kforce Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Kforce Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31

cash flows from operating activities:
net income	10,449,000	8,145,000	11,061,000	14,209,000	14,157,000	10,987,000	15,716,000	10,575,000	18,574,000	16,210,000	7,072,000	22,262,000	26,916,000	19,181,000	20,560,000	20,168,000	21,188,000	13,261,000	18,285,000	18,763,000	9,885,000	9,106,000	14,208,000	14,940,000	74,859,000	26,855,000	16,356,000	16,177,000	16,272,000	9,175,000	6,140,000	10,099,000	11,144,000	5,902,000	9,239,000	9,020,000	10,864,000	3,650,000	11,901,000	13,545,000	11,593,000	5,785,000	8,945,000	65,018,000	10,703,000	6,249,000	-8,234,000	8,979,000	6,948,000	3,094,000	6,120,000	9,268,000	-33,167,000	4,076,000	7,085,000	8,446,000	6,785,000	4,840,000	6,338,000	6,444,000	5,144,000	2,708,000	3,533,000	2,272,000	3,907,000	3,161,000	-107,878,000	7,892,000	8,700,000	7,178,000
adjustments to reconcile net income to cash from operating activities:
deferred income tax provision	-1,444,000	-235,000	981,000	-1,391,000	-1,217,000	-244,000	2,404,000	-2,763,000	705,000	1,301,000	-1,305,000	-1,805,000	-2,130,000	8,321,000	2,123,000	-597,000	-32,000	931,000	2,116,000	-673,000	-3,615,000	-126,000	-1,071,000	-713,000	20,049,000	-18,314,000	2,014,000	-527,000	-539,000	41,000	8,265,000	1,240,000	980,000	1,758,000	654,000	-846,000	-1,144,000	3,343,000	1,506,000	-396,000	584,000	686,000		-324,000	-224,000	1,976,000		-870,000	1,818,000	503,000	-558,000	771,000	-21,842,000	4,493,000	175,000	-1,129,000				456,000	1,335,000	-14,000		999,000	-97,000	262,000		-843,000	-578,000	902,000
benefit from (recoveries of) credit losses	-7,000	69,000
depreciation and amortization	1,390,000	1,464,000	1,491,000	1,543,000	1,555,000	1,333,000	1,236,000	1,202,000	1,340,000	1,234,000	1,213,000	1,045,000	1,076,000	1,093,000	1,080,000	1,026,000	1,192,000	1,202,000	1,174,000	1,308,000	1,380,000	1,393,000	1,430,000	1,428,000	1,651,000	1,972,000	2,019,000	2,074,000	2,057,000	2,115,000	2,135,000	2,165,000	2,105,000	2,103,000	2,094,000	2,102,000	2,263,000	2,337,000	2,438,000	2,583,000	2,428,000	2,400,000	2,517,000	2,778,000	2,400,000	2,363,000	2,451,000	2,536,000	2,462,000	2,397,000	2,371,000	2,659,000	2,877,000	2,955,000	3,075,000	3,072,000	3,211,000	3,336,000	3,262,000	3,236,000	3,137,000	2,976,000	2,919,000	2,829,000	2,885,000	3,040,000	3,174,000	3,028,000	3,670,000	3,952,000
stock-based compensation expense	3,618,000	3,656,000	3,496,000	3,549,000	3,498,000	3,501,000	3,145,000	5,967,000	4,309,000	4,326,000	4,362,000	4,445,000	4,411,000	4,437,000	3,551,000	3,512,000	3,533,000	3,403,000	2,888,000	2,908,000	2,903,000	2,896,000	2,443,000	2,419,000	2,430,000	2,620,000	2,239,000	2,006,000	2,292,000	2,260,000	1,933,000	1,798,000	1,805,000	2,064,000	1,663,000	1,336,000	1,762,000	1,944,000		1,348,000
noncash lease expense	918,000	971,000	918,000	917,000	910,000	938,000	954,000	1,308,000	673,000	1,130,000	1,370,000	1,363,000	1,448,000	1,502,000	1,517,000	1,549,000	1,329,000	1,114,000	1,107,000	1,306,000	1,565,000	1,521,000	1,452,000	1,643,000	1,525,000	1,662,000
other	-836,000	382,000	290,000	308,000	-1,397,000	404,000	49,000	307,000	318,000	50,000	272,000	-683,000	171,000	190,000	355,000	236,000	203,000	242,000		89,000	89,000	87,000	89,000	86,000	90,000	87,000	100,000	88,000	104,000	96,000	143,000	150,000	323,000	272,000	142,000	55,000	68,000	56,000	14,000	109,000	57,000	6,000	-45,000	28,000	-157,000	22,000	152,000	23,000	42,000	40,000	-58,000	27,000	36,000	50,000	-44,000	152,000	101,000	42,000	-189,000	260,000	60,000	41,000	-215,000	144,000	-68,000	-58,000
increase in operating assets
trade receivables	10,660,000	-4,911,000	13,606,000	1,302,000	6,186,000	-3,456,000	14,421,000	1,732,000	16,547,000	2,601,000	11,522,000	4,291,000	-6,948,000	-12,914,000	4,437,000	-3,032,000	-23,364,000	-15,001,000	2,222,000	12,500,000	-7,409,000	-20,176,000	9,627,000	-2,158,000	-5,452,000	-7,377,000	2,401,000	927,000	-1,829,000	-12,350,000	17,843,000	-18,975,000	2,262,000	-21,665,000	2,669,000	6,426,000	-5,631,000	-11,867,000	17,452,000	-1,252,000	-12,157,000	180,000	-2,036,000	-15,522,000	-13,563,000	-9,218,000	3,263,000	-17,656,000	-466,000	-13,212,000	17,694,000	10,408,000	-7,342,000	-16,462,000	12,067,000	-20,371,000	-3,295,000	-13,733,000	7,418,000	-10,674,000	-410,000	-18,700,000	4,982,000	-825,000	3,431,000	1,865,000	14,011,000	7,057,000	8,664,000	2,016,000
other assets	-5,821,000	-4,988,000	-4,717,000	-3,677,000	213,000	-608,000	-1,015,000	-2,750,000	2,218,000	243,000	-7,210,000	1,648,000	-1,060,000	-2,577,000	-3,395,000	-1,494,000	-4,566,000	-324,000	549,000	-2,524,000	-2,058,000	-452,000	-2,654,000	-4,936,000	-556,000	-1,493,000	54,000	839,000	32,000	69,000	-12,000	-428,000	11,000	-127,000	-519,000	-59,000	178,000	-95,000	24,000	-62,000	-170,000	-90,000	15,000	-119,000	71,000	6,000	-196,000	53,000	17,000	69,000	116,000	79,000	36,000	13,000	2,000	36,000	31,000	6,000	145,000	-187,000	-159,000	46,000	5,000	-167,000	121,000	47,000	3,000	231,000	1,737,000	-1,495,000
increase in operating liabilities
accrued payroll costs	-1,254,000	2,273,000	-7,432,000	7,058,000	45,000	5,982,000	-8,546,000	3,602,000	-7,184,000	-1,230,000	-33,028,000	-6,541,000	2,119,000	15,447,000	-1,378,000	-9,287,000	4,799,000	12,203,000	-9,099,000	20,908,000	8,459,000	2,129,000	-5,016,000	8,285,000	918,000	380,000	-3,457,000	2,404,000	2,086,000	317,000	-6,552,000	5,934,000	979,000	1,593,000	-8,142,000	-1,798,000	4,016,000	4,604,000	-17,570,000	8,213,000	7,239,000	-3,385,000	-6,922,000	3,490,000	1,072,000	2,112,000	587,000	4,028,000	2,356,000	451,000	-4,869,000	2,266,000	-1,284,000	3,646,000	-3,425,000	1,399,000	4,496,000	-1,075,000	-6,289,000	9,243,000	3,785,000	-2,968,000		7,058,000	3,569,000	-5,923,000	-3,821,000	2,736,000	2,474,000	-5,187,000
other liabilities	692,000	-6,577,000	2,132,000	7,008,000	-3,037,000	-5,628,000	-6,398,000	9,574,000	-16,208,000	-7,930,000	11,637,000	420,000	5,342,000	2,897,000	-16,866,000	10,551,000	8,746,000	5,504,000	-4,278,000	-715,000	21,944,000	3,538,000	-1,173,000
cash from operating activities	18,365,000	249,000	21,790,000	30,979,000	20,936,000	13,169,000	22,409,000	28,625,000	21,375,000	19,056,000	12,742,000	7,303,000	32,018,000	38,742,000	12,955,000	23,369,000	14,148,000	22,426,000	15,288,000	54,905,000	35,961,000	3,005,000	20,107,000	24,180,000	10,541,000	11,789,000	23,048,000	26,416,000	28,009,000	10,250,000	23,690,000	110,000	16,052,000	-10,513,000	10,112,000	13,678,000	12,601,000	3,056,000	15,024,000	29,153,000	14,595,000	11,408,000	-29,291,000	-8,430,000	6,200,000	5,939,000	-3,307,000	5,018,000	7,168,000	-8,414,000	28,135,000	20,137,000	5,233,000	2,473,000	17,320,000	3,042,000	14,504,000	-3,626,000	15,729,000	15,691,000	13,126,000	-15,956,000	11,194,000	14,664,000	20,118,000	-3,280,000	24,437,000	26,793,000	23,936,000	14,162,000
cash flows from investing activities:
capital expenditures	-4,141,000	-4,149,000	928,000	-3,522,000	-3,104,000	-1,875,000	-1,687,000	-1,126,000	-3,078,000	-1,872,000	-3,453,000	-1,198,000	-1,237,000	-2,221,000	-1,415,000	-2,107,000	-1,569,000	-1,350,000	-1,179,000	-1,503,000	-1,822,000	-1,971,000	-2,631,000	-3,544,000	-2,688,000	-1,496,000	-1,165,000	-889,000	-1,647,000	-1,469,000	-422,000	-1,080,000	-2,072,000	-2,272,000	-3,011,000	-6,227,000	-1,888,000	-1,294,000	-597,000	-4,127,000	-2,215,000	-1,389,000	-1,224,000	-1,688,000	-1,889,000	-1,210,000	-2,102,000	-1,828,000	-2,299,000	-1,916,000	-1,305,000	-1,673,000	-1,909,000	-959,000	-2,159,000	-1,431,000	-1,316,000	-1,589,000	-3,108,000	-2,046,000	-30,924,000	-1,669,000	-959,000	-1,010,000	-1,170,000	-708,000	-1,457,000	-1,532,000	-3,703,000	-1,813,000
free cash flows	14,224,000	-3,900,000	22,718,000	27,457,000	17,832,000	11,294,000	20,722,000	27,499,000	18,297,000	17,184,000	9,289,000	6,105,000	30,781,000	36,521,000	11,540,000	21,262,000	12,579,000	21,076,000	14,109,000	53,402,000	34,139,000	1,034,000	17,476,000	20,636,000	7,853,000	10,293,000	21,883,000	25,527,000	26,362,000	8,781,000	23,268,000	-970,000	13,980,000	-12,785,000	7,101,000	7,451,000	10,713,000	1,762,000	14,427,000	25,026,000	12,380,000	10,019,000	-30,515,000	-10,118,000	4,311,000	4,729,000	-5,409,000	3,190,000	4,869,000	-10,330,000	26,830,000	18,464,000	3,324,000	1,514,000	15,161,000	1,611,000	13,188,000	-5,215,000	12,621,000	13,645,000	-17,798,000	-17,625,000	10,235,000	13,654,000	18,948,000	-3,988,000	22,980,000	25,261,000	20,233,000	12,349,000
proceeds from company-owned life insurance				0																																							0	0
premiums paid for company-owned life insurance	0	-686,000	-591,000	-627,000	-621,000	-529,000																																																							-557,000	-1,640,000	-594,000	-551,000	-588,000	-1,612,000	-889,000	-1,073,000	-1,008,000	-1,624,000
cash from investing activities	-2,758,000	-4,835,000	337,000	-4,149,000	-1,348,000	-2,404,000	-2,330,000	-1,698,000			-4,626,000	-3,698,000	-3,237,000	-2,721,000	-3,415,000			-3,350,000	-2,679,000	-1,503,000	-774,000	-1,971,000	-4,841,000	-2,986,000	113,508,000	-2,496,000	-1,165,000	111,000	-1,647,000	-1,469,000	-422,000	-80,000	-2,072,000	-2,272,000	-3,011,000	-6,227,000	-1,888,000	-1,294,000	-597,000	-4,127,000	-2,251,000	-1,389,000	-3,777,000	116,401,000			-1,755,000	-2,309,000	-2,413,000	-2,070,000		6,320,000	-1,194,000	46,298,000	-3,344,000	-2,128,000	-1,814,000	-2,804,000	-3,675,000	2,614,000	-31,472,000	-3,235,000	-1,500,000	-1,812,000	-1,083,000	-1,644,000	-40,754,000	-1,098,000	5,837,000	-3,427,000
cash flows from financing activities:
proceeds from credit facility	151,700,000	171,800,000	127,400,000	32,000,000	34,000,000	107,600,000	168,000,000	83,900,000	168,300,000	174,200,000									0	0	0	35,000,000	0	0	1,800,000	78,300,000	22,800,000	93,000,000	141,200,000	193,400,000	151,300,000	276,100,000	336,640,000	274,553,000	259,295,000	222,760,000
payments on credit facility	-147,200,000	-139,000,000	-121,600,000	-41,800,000	-38,100,000	-108,400,000	-147,800,000	-87,100,000	-166,000,000	-177,500,000	-12,600,000	0											0	0	-19,300,000	-67,600,000	-30,300,000	-114,300,000	-163,800,000	-186,723,000	-160,877,000	-274,129,000	-344,477,000	-254,134,000	-249,078,000	-217,215,000
repurchases of common stock	-11,177,000	-21,066,000	-20,749,000	-9,960,000	-8,381,000	-2,848,000	-33,554,000	-16,856,000	-13,488,000	-11,126,000	-32,810,000	-22,503,000	-9,330,000	-10,270,000	-21,803,000	-15,036,000	-13,058,000	-16,313,000	-5,990,000	-30,000	-10,123,000	-19,470,000	-32,506,000	-40,401,000	-36,671,000	-14,875,000	-9,722,000	-336,000	-91,000	-12,038,000	-10,396,000	-1,274,000	-65,000	-2,887,000	-14,226,000	-9,602,000	-101,000	-22,084,000	-13,588,000	-7,205,000	-9,171,000	-8,507,000	-43,221,000	-36,566,000	-21,691,000	-293,000	-757,000	-5,834,000	-14,771,000	-8,448,000	-18,959,000	-9,116,000	-15,677,000	-623,000															-7,825,000	-13,013,000
cash dividends	-6,900,000	-7,051,000	-6,954,000	-7,053,000	-7,101,000	-7,128,000	-6,720,000	-6,895,000	-6,944,000	-7,003,000	-5,863,000	-5,977,000	-6,093,000	-6,094,000	-5,284,000	-5,304,000	-4,746,000	-4,786,000	-4,168,000	-4,164,000			-3,882,000	-4,042,000			-4,467,000	-4,461,000
cash from financing activities	-13,579,000	4,681,000	-21,905,000	-26,813,000	-19,584,000	-10,778,000	-20,082,000	-26,952,000	-18,128,000	-21,443,000	-13,084,000	-28,490,000	-115,434,000	-16,383,000	-28,182,000	-20,410,000	-17,883,000	-21,221,000	-10,396,000	-4,500,000	-14,590,000	10,909,000	-36,755,000	-44,921,000	-59,261,000	-9,146,000	-22,237,000	-26,534,000	-26,146,000	-8,903,000	-23,592,000	-2,859,000	-13,186,000	14,041,000	-6,544,000	-7,569,000	-10,590,000	-2,339,000	-14,176,000	-25,431,000	-12,621,000	-9,329,000	33,189,000	-108,150,000	-4,672,000	-4,957,000	5,134,000	-2,970,000	-4,598,000	10,010,000	-33,153,000	-21,851,000	-4,089,000	-48,848,000	-14,062,000	-574,000	-12,453,000	5,823,000	-11,453,000	-18,261,000	17,613,000	17,522,000	-7,381,000	-12,820,000	-19,468,000	5,164,000				-10,984,000
change in cash and cash equivalents	2,028,000	95,000	222,000	17,000	4,000	-13,000	-3,000	-25,000	-24,000	50,000	-4,968,000	-24,885,000	-86,653,000	19,638,000	-18,642,000	-1,648,000	15,938,000	-2,145,000	2,213,000	48,902,000	20,597,000	11,943,000	-21,489,000	-23,727,000	64,788,000	147,000	-354,000	-7,000	216,000	-122,000	-324,000	-2,829,000	794,000	1,256,000	557,000	-118,000	123,000	-577,000	251,000	-405,000	-277,000	690,000	121,000	-179,000	480,000	-59,000
cash and cash equivalents, beginning of period	0	349,000		0	0	119,000		0	0	121,000		0	0	96,989,000		0	0	103,486,000		0	0	19,831,000		0
cash and cash equivalents, end of period	2,028,000	444,000		17,000	4,000	106,000		-25,000	-24,000	171,000		-24,885,000	-86,653,000	116,627,000		-1,648,000	15,938,000	101,341,000		48,902,000	20,597,000	31,774,000		-23,727,000
benefit from credit losses			-36,000	153,000	23,000	-40,000	443,000	-129,000	83,000	371,000	105,000	-59,000	-344,000	172,000	150,000	42,000	671,000	-852,000		-112,000	606,000	2,229,000
loss on equity method investment							0	0	0	750,000	1,087,000	897,000	1,015,000	825,000	771,000	687,000	531,000	491,000	444,000	103,000	539,000	595,000	472,000
reserve related to note receivable
impairment of equity method investment
payment of benefit under terminated pension plan											0
proceeds received from company-owned life insurance
proceeds from the sale of our joint venture interest							0	0	0	5,059,000
note receivable issued to our joint venture									0	-750,000
equity method investment															-2,000,000	-2,500,000	-2,500,000	-2,000,000	-1,500,000	0			-1,500,000	0
cash and cash equivalents at beginning of year																																													0	875,000
cash and cash equivalents at end of year																																													480,000	816,000
defined benefit pension plans expense																											455,000	456,000	455,000	455,000	245,000	213,000	240,000	239,000		444,000	457,000	497,000
(premiums paid for) cash proceeds received from company-owned life insurance
net proceeds from the sale of assets held for sale																							-710,000	558,000
premiums paid for company-owned life insurance policies																																																			-476,000	104,000	-19,000	-1,069,000			-537,000	-1,216,000
cash from (used) in investing activities										2,437,000
payments on other financing arrangements										-14,000	-11,000	-10,000	-11,000	-19,000		-70,000	-79,000	-122,000		-306,000	-305,000	-328,000	-367,000	-478,000	-335,000	-540,000	-548,000	-437,000	-485,000	-569,000	-566,000	-503,000	-553,000	-526,000	-459,000	-434,000	-452,000	-485,000
gain on disposal or impairment of assets											36,000	-15,000
cash proceeds received from company-owned life insurance
defined benefit pension plan expense																0	1,905,000	252,000		210,000	211,000	211,000		216,000	215,000	216,000
contributions to workllama joint venture
note receivable issued to workllama joint venture
net proceeds from the sale of assets																0
contributions to workllama, joint venture
note receivable issued to workllama, joint venture
loss on disposal or impairment of assets														168,000					27,000	703,000	1,077,000	15,000	7,000
contributions to equity method investment														-500,000
gain on sale of assets held for sale
payments on other financing arrangements, payment of contingent consideration liability and other
payments of loan financing fees																															-34,000	-8,000
(gain) loss on disposal or impairment of assets																8,000
proceeds from the sale of assets held within the rabbi trust																				0																										1,006,000	1,433,000	249,000	547,000	1,049,000	2,871,000	654,000
cash from ( used in) investing activities
benefit from bad debts																							273,000	139,000	448,000	349,000		543,000	593,000	368,000
loss on deferred compensation plan investments																			147,000			39,000	165,000			89,000	179,000	136,000	138,000	110,000	171,000	133,000	102,000	104,000	186,000	108,000	132,000	171,000	-115,000
contingent consideration liability remeasurement and other
gain on sale of discontinued operations																								402,000																			19,000								115,000	91,000	0	-36,624,000													0	-1,392,000
gain on deferred compensation plan investments
cash dividend																						-4,293,000				-4,406,000				-2,973,000	-3,019,000	-3,045,000	-3,043,000	-3,037,000	-3,050,000	-3,099,000	-3,152,000	-3,146,000	-3,284,000	-3,060,000	-3,089,000	-3,112,000	-3,169,000	-3,088,000	-3,212,000	-3,307,000
contingent consideration liability remeasurement																							0	0	-427,000	886,000													-203,000	0
payment of contingent consideration liability																							0	0
income tax refund receivable																								-1,000	-105,000	206,000	-14,000	641,000	-171,000	6,341,000	-5,223,000	-176,000	-820,000	-725,000	568,000	226,000	-899,000	459,000	1,688,000	-220,000	-1,271,000	2,588,000	-3,272,000	4,491,000	744,000	2,446,000				-427,000	-1,472,000	-173,000	3,251,000	-3,106,000	-206,000	2,778,000	-1,224,000	4,077,000	-3,146,000	0	-1,404,000	-879,000	2,238,000	-2,177,000	-14,000	194,000	1,000	-26,000	-33,000	-52,000
prepaid expenses and other current assets																								-138,000	-2,215,000	894,000	485,000	-631,000	-1,995,000	91,000	600,000	-1,842,000	-209,000	-20,000	1,041,000	1,022,000	-2,290,000	-1,404,000	614,000	701,000	-137,000	-68,000	464,000	1,775,000	-432,000	-1,277,000	-439,000	1,050,000	-1,750,000	-2,031,000	496,000	1,790,000	-3,213,000	-1,319,000	1,482,000	394,000	-624,000	-1,632,000	925,000	586,000	267,000	-1,977,000	816,000	679,000	321,000	-1,873,000	923,000	178,000	997,000	-2,334,000
accounts payable and other accrued liabilities																								305,000	-3,508,000	5,841,000	285,000	-194,000	5,937,000	-2,096,000																										2,721,000	714,000	47,000		3,019,000	-1,198,000	1,031,000		-1,896,000	4,185,000	-3,483,000		-935,000	-2,344,000	1,593,000
income taxes payable																								-1,388,000	-2,198,000	2,951,000	-1,587,000	1,058,000	1,999,000	3,388,000	-486,000	0	-358,000	623,000	-998,000	-616,000	326,000	799,000	-4,786,000	2,077,000	639,000	413,000	-30,529,000	-7,215,000	-1,457,000	3,672,000	-3,317,000	3,284,000	-1,157,000	287,000	861,000	-676,000	-415,000	1,037,000	-660,000	607,000	-942,000	980,000	-24,000	273,000	0	-279,000	280,000	-903,000	-1,499,000	-1,731,000	896,000	633,000	-2,423,000	2,307,000
supplemental disclosure of cash flow information
cash paid during the period for:
income taxes																																																2,642,000	7,111,000	1,537,000		6,165,000	1,720,000	978,000		2,624,000	4,638,000	-3,406,000		3,584,000	3,635,000	730,000				3,659,000		4,432,000	8,160,000	1,999,000
operating lease liabilities
interest																																																235,000	171,000	152,000		-3,000	-3,000	266,000		241,000	178,000	181,000		222,000	218,000	136,000				259,000		296,000	528,000	844,000
non-cash financing and investing transactions:
rou assets obtained from new operating leases
contingent contribution for equity method investment
unsettled repurchases of common stock																																																						14,883,000
employee stock purchase plan																																																156,000	165,000	141,000		124,000	213,000	166,000		174,000	188,000	138,000										198,000	213,000	235,000
equipment acquired under finance leases
shares tendered in payment of exercise price of stock options
(gain) loss on deferred compensation plan investments
loss on disposal or impairment of property and equipment																									169,000	801,000
other long-term liabilities																									2,751,000	-6,836,000	1,203,000	419,000	578,000	-130,000	-1,996,000	-398,000	-463,000	-913,000	674,000	-297,000	-1,555,000	1,039,000	555,000	2,129,000	227,000	395,000	-182,000	-2,206,000	870,000	-799,000	-470,000	502,000	-112,000	163,000	162,000	-366,000	-1,011,000	-482,000	985,000	247,000	-260,000	-4,074,000	1,330,000	382,000	186,000	-1,431,000	695,000	163,000	196,000	-76,000	1,030,000	1,409,000	-417,000	1,586,000
cash and cash equivalents at beginning of period																										112,000		0	0	379,000		0	0	1,482,000		0	0	1,497,000		0	0	1,238,000						0	0	1,381,000		0	0	939,000		0	0	1,055,000		0	0	2,812,000		0	0	660,000		0	0	1,083,000
cash and cash equivalents at end of period																										259,000		-7,000	216,000	257,000		-2,829,000	794,000	2,738,000		-118,000	123,000	920,000		-405,000	-277,000	1,928,000						-261,000	157,000	907,000		4,606,000	-50,000	862,000		340,000	237,000	448,000		44,000	-733,000	1,143,000		32,000	-433,000	900,000		-1,135,000	1,222,000	834,000
benefit from bad debt
gain on sale of global's assets																															0
proceeds from sale of global's assets																											0				0
proceeds from exercise of stock options, net of shares tendered in payment of exercise																																							0				182,000
proceeds from other financing arrangements																																			927,000	0
proceeds from exercise of stock options																																0	0	72,000		0	63,000	109,000			136,000	245,000			235,000	467,000																				198,000			69,000	6,000
accounts payable and other current liabilities																															-216,000	2,805,000	-2,013,000	-2,113,000	194,000	-3,211,000	3,645,000	-2,548,000	-84,000	-496,000	2,569,000	-201,000	799,000	2,906,000	5,400,000	-3,452,000	-10,058,000	305,000	-1,435,000	-1,283,000	2,439,000	-7,234,000	-258,000	15,966,000
proceeds from the disposition of assets held within the rabbi trust																																							0	0			338,000	957,000
purchase of assets held within the rabbi trust																																							0	0			-280,000	-756,000	-563,000	-837,000	-1,086,000	-747,000	-661,000	-1,203,000
benefit from bad debts on accounts receivable																																540,000	-36,000	392,000	401,000	-199,000	418,000	356,000	-308,000	458,000	356,000	1,047,000	-255,000	159,000	452,000	469,000
defined benefit pension and post-retirement plans expense
excess tax benefit attributable to stock-based compensation																																			-47,000	-35,000	-9,000	-285,000	-143,000	-97,000	-75,000	-236,000		-95,000	0	-33,000	-68,000	-17,000	-15,000	-10,000	659,000	0	0	-1,789,000	-16,000	-36,000	0	-826,000	-468,000	-56,000	15,000	-1,010,000
gain from company-owned life insurance proceeds																																											0	0
increase in operating assets:
increase in operating liabilities:
acquisition, net of cash received
proceeds from disposition of business																																											0									7,235,000	0	48,326,000
payments of deferred financing fees																																			0
proceeds from bank line of credit																																						251,095,000	161,473,000	126,714,000	158,675,000	157,806,000	239,581,000	129,277,000	216,594,000	98,975,000	158,566,000	150,637,000	141,364,000	141,121,000	21,000,000	4,109,000	124,013,000	92,851,000	103,208,000	158,811,000	110,829,000	115,620,000	103,560,000	69,150,000	152,845,000	122,935,000	40,145,000	77,215,000	53,292,000	113,830,000	146,630,000	67,343,000	50,271,000	130,988,000
payments on bank line of credit																																						-228,113,000	-161,894,000	-139,442,000	-159,380,000	-156,813,000	-158,923,000	-198,349,000	-196,063,000	-100,366,000	-149,370,000	-147,339,000	-130,800,000	-122,572,000	0	-15,101,000	-113,021,000	-142,377,000	-113,066,000	-118,361,000	-117,235,000	-101,105,000	-112,735,000	-87,150,000	-134,045,000	-106,735,000	-49,935,000	-89,288,000	-72,429,000	-107,852,000	-120,608,000	-88,343,000	-70,271,000	-128,318,000
goodwill impairment																																																				0
stock-based compensation																																										1,291,000	944,000	680,000	605,000	799,000	1,633,000	336,000	327,000	274,000	53,000	38,000	0	25,649,000	3,230,000	3,088,000	2,837,000	2,821,000	1,499,000	1,631,000	1,511,000	1,395,000			717,000	902,000	718,000	1,458,000
pension and post-retirement benefit plans expense																																							451,000	427,000	476,000	492,000
amortization of deferred financing costs																																							32,000	29,000	30,000	31,000																					38,000
decrease (increase) in operating assets:
proceeds from financing agreement
payments of capital expenditure financing																																							-318,000	-326,000	-306,000	-324,000	-402,000	-232,000	-342,000	-304,000	-323,000	-346,000	-386,000	-397,000	-395,000	-459,000	-446,000	-502,000	-313,000	-254,000
payments of loan financing costs
short-term vendor financing																																							378,000	-2,209,000	439,000	1,140,000	-306,000	466,000	-193,000	-127,000	-30,000	-189,000	-76,000	115,000	629,000	-1,284,000	916,000	-8,000	-16,000	156,000	70,000	77,000	-245,000	42,000	-822,000	502,000	244,000	4,000	149,000	-138,000
payment of loan financing fees																																														-35,000
deferred compensation liability increase																																									25,000	639,000	743,000	-229,000	638,000	330,000	1,440,000	1,109,000	255,000	1,190,000	187,000	798,000	-603,000	1,729,000		-2,657,000	-54,000	838,000	1,393,000	1,525,000	-1,090,000	603,000	592,000	1,678,000			-2,429,000	-1,661,000	69,000	-1,240,000
gain on cash surrender value of company-owned life insurance																																									36,000	-565,000	-492,000	374,000	-688,000	-230,000														-1,257,000								2,037,000	78,000	1,387,000
decrease (increase) in operating assets
deferred income tax benefit
tax benefit attributable to stock-based compensation																																											266,000	142,000	61,000	126,000	295,000	56,000	23,000	25,000	-608,000	0	5,000	1,804,000	-11,000	37,000	28,000	1,162,000	799,000	75,000			33,000
pension and postretirement benefit plans expense																																												58,000	554,000	378,000	393,000	966,000	908,000	970,000	1,116,000	1,123,000	1,134,000	1,132,000	1,089,000	1,086,000	1,095,000	1,099,000	1,004,000	1,028,000	985,000	1,008,000	338,000	714,000	709,000	241,000
paymet of loan financing fees
cash (used in) investing activities																																														-1,041,000
goodwill and intangible asset impairment
benefit from (recovery of) bad debts on accounts receivable and other accounts receivable reserves																																																			-310,000	46,000	1,060,000	1,064,000
(gain) loss on cash surrender value of company-owned life insurance																																																															-409,000	-1,448,000
increase in operating assets, net of acquisitions:
increase in operating liabilities, net of acquisitions:
proceeds from disposition of business, net of cash
payments of deferred loan financing costs																																																							-3,000
benefit from bad debts on accounts receivable and other accounts receivable reserves																																																434,000	241,000	294,000
gain on cash surrender value of company-owned life insurance policies																																																-1,117,000	-274,000	-1,208,000			669,000	-1,359,000				-626,000
income tax receivable																																																1,017,000
proceeds from exercise of stock options, net of shares tendered in payment of the exercise price of stock options																																																84,000	56,000	181,000	427,000	0	126,000	22,000	265,000	86,000	39,000	68,000	117,000	125,000	139,000	1,552,000	2,780,000	746,000
increase in cash and cash equivalents																																																														-1,669,000			-433,000	240,000
supplemental cash flow information:
non-cash transaction information:
equipment acquired under capital leases																																																561,000	694,000	702,000		240,000						115,000				189,000
shares tendered in payment of the exercise of stock options
decrease in cash and cash equivalents																																																	157,000	-474,000			-50,000	-77,000		340,000	237,000	-607,000		44,000										-249,000
cash paid (received) during the period for:
capital expenditures not yet paid
shares tendered in payment of the exercise price of stock options																																																				0	0	161,000						0	0	1,316,000
goodwill impairment and intangible asset impairment
proceeds from borrowings against cash surrender value of company-owned life insurance policies
cash from in investing activities
excess tax benefit from stock-based compensation																																																														1,010,000	1,805,000
(gain) loss on cash surrender value of company-owned life insurance policies																																																														-218,000
payments of deferred loan financing
recovery of bad debts on accounts receivable and other accounts receivable reserves																																																							11,000	253,000	-278,000	-911,000
alternative long-term incentive award																																																								5,000	4,000	3,000	722,000	281,000	280,000	280,000	617,000	978,000	513,000	359,000
deferred compensation liability decrease (increase)
proceeds from escrow																																																															0
shares repurchased for minimum tax withholding on restricted stock awards, stock option exercises and sars																																																							0	0	-12,000	-1,573,000
open market repurchases of common stock																																																							-4,153,000	-40,601,000	-5,608,000	-7,696,000									-9,936,000
gain on cash surrender value of corporate-owned life insurance
premiums paid for corporate-owned life insurance policies
proceeds from borrowings against cash surrender value of corporate-owned life insurance policies
shares tendered in payment of the exercise price of stock options and sars																																																								0	12,000	2,389,000
equipment acquired under capital lease																																																								683,000				1,300,000									3,000	1,007,000
unsettled open market repurchases of common stock
payment of capital expenditure financing																																																										-394,000	-331,000	-483,000	-476,000	-462,000	-599,000	-500,000	-396,000	-557,000	-613,000	-651,000	-795,000	-647,000
(recovery of) benefit from bad debts on accounts receivable and other accounts receivable reserves
loss on asset sales																																																																		37,000
acquisitions, net of cash received																																																															51,000	-251,000	0	91,000
proceeds from disposition of businesses																																																																			0	1,500,000
recovery of bad debts on accounts receivable and fallouts																																																												-574,000	-637,000	-21,000
intangible asset impairment charge																																																																0
proceeds from borrowings against cash surrender value of company-owned life insurance policies, net of premiums paid
proceeds from escrow account																																																																	589,000	581,000
shares repurchased for minimum tax withholding on restricted stock and stock option exercises																																																												-1,000	-13,000	-1,280,000		-1,901,000
tax benefit (deficiency) attributable to stock-based compensation																																																														1,453,000
cash proceeds from asset sales																																																																		4,000	-4,000
gain on asset sales
shares repurchased for minimum tax withholding on restricted stock awards and stock option exercises
(recovery of) benefit from bad debts on accounts receivable and fallouts																																																																143,000	-189,000	-523,000
tax benefit attributable to option exercises																																																																			-162,000	554,000	23,000	1,000
excess tax benefit attributable to option exercises																																																																			-6,000
loss on asset sales/disposals
cash proceeds from sale of assets																																																																					12,000	10,000
deferred compensation liability decrease																																																																		-649,000
tax (deficiency) benefit attributable to restricted stock and stock option exercises																																																																		-17,000
loss on cash surrender value of company-owned life insurance policies																																																																		945,000
shares repurchased for minimum tax withholding on restricted stock																																																																		-317,000
benefit from (recovery of) bad debts on accounts receivable and fallouts
amortization of alternative long-term incentive expense
cash proceeds received upon surrender of company-owned life insurance
payment of loan financing costs
proceeds from exercise of stock options, net of shares tendered in payment of exercise price of stock options																																																																			15,000
benefit from bad debts on accounts receivable and fallouts																																																																				3,742,000	661,000	1,046,000
supplemental executive retirement plans expense																																																																				753,000	631,000	732,000
amortization of alternative long-term incentive award
gain on asset sales/disposals																																																																				-7,000	137,000	30,000
minimum tax withholding on restricted stock awards and stock option exercises
cash (used in) financing activities																																																																				-26,830,000
release of funds from escrow – adjustment to purchase price
proceeds from discontinued operations held in escrow																																																																				0
cash from connection with acquisitions
stock based compensation																																																																						1,740,000
cash flows used by investing activities:
cash from connection with acquisitions, net:
excess tax benefit attributable to stock options and restricted stock
deferred compensation expense
(gain) loss on asset sales/disposals
release of restricted cash
repayment of capital expenditure financing
(recovery of) benefit from bad debts on accounts receivable
amortization of stock based compensation
supplemental executive retirement plan expense
loss on asset impairment
trade and notes receivables
bank overdrafts
investments in cash surrender value of company owned life insurance
cash proceeds received upon surrender of company owned life insurance

We provide you with 20 years of cash flow statements for Kforce stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kforce stock. Explore the full financial landscape of Kforce stock with our expertly curated income statements.

The information provided in this report about Kforce stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.